About MyoKardia

We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease.

For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
1000 Sierra Point Parkway, Brisbane, California 94005, US
description icon
Founded
2012
description icon
Keywords
Biotechnology, Drug Discovery, Drug Development, R&D, Therapeutics, Precision Medicine, Cardiovascular Disease, Heart Failure, Cardiomyopathy, Genetic Heart Disease

MyoKardia Alternatives

Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology

Frequently Asked Questions about MyoKardia

Who is the CEO of MyoKardia?

Jacob Hayze is the CEO of MyoKardia. To contact Jacob Hayze email at [email protected].

Who are the decision makers in MyoKardia?

The decision makers in MyoKardia are Elina Lavit, James Spudich, Jaycee Martin, etc. Click to Find MyoKardia decision makers emails.

How can I contact Bristol Myers Squibb for inquiries about their cardiovascular treatments?

You can reach Bristol Myers Squibb by visiting their official website at www.bms.com and navigating to the 'Contact Us' section. There, you'll find options for customer service inquiries, including phone numbers and email addresses for specific departments related to cardiovascular treatments.

Where can I find a directory of staff members at Bristol Myers Squibb?

A staff directory is typically not publicly available for privacy and security reasons. However, you can find key contacts and leadership information on the Bristol Myers Squibb website under the 'About Us' section, which provides insights into their executive team and organizational structure.

What services does Bristol Myers Squibb offer for patients with heart disease?

Bristol Myers Squibb specializes in developing innovative therapies for cardiovascular diseases, including heart failure and genetic heart disease. They focus on precision medicine to tailor treatments to individual patient needs, enhancing the effectiveness of their drug development efforts.

How does Bristol Myers Squibb support research and development in cardiovascular medicine?

Bristol Myers Squibb invests heavily in R&D to advance treatments for cardiovascular diseases. Their commitment includes partnerships with research institutions and a focus on drug discovery, ensuring they remain at the forefront of developing new therapies for patients with serious heart conditions.

Can I find information about clinical trials related to cardiovascular diseases on the BMS website?

Yes, the Bristol Myers Squibb website provides information about ongoing clinical trials for their cardiovascular treatments. You can access details about trial phases, eligibility criteria, and how to participate by visiting the 'Clinical Trials' section on their site.

What industries does Bristol Myers Squibb serve with its cardiovascular solutions?

Bristol Myers Squibb serves the biotechnology and pharmaceutical industries, focusing on developing therapeutics for cardiovascular diseases. Their solutions are aimed at healthcare providers, researchers, and patients, ensuring comprehensive support across the healthcare ecosystem for heart disease management.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more